Die chronische intestinale Pseudoobstruktion (CIPO) ist ein seltenes Krankheitsbild, bei dem eine schwere intestinale Motilitätsstörung zur Behinderung des Chymustransports bis zum Vollbild eines mechanischen Ileus führt, ohne dass ein Passagehindernis vorliegt. Eine CIPO kann als primäre Erkrankung oder sekundär auftreten aufgrund muskulärer Erkrankungen, neurologischer, metabolischer und endokriner Störungen, aber auch postinfektiös, postoperativ, nach abdomineller Bestrahlung, durch Medikamente oder Noxen. Beim Vollbild ist die typische Anamnese mit frustranen Laparotomien unter dem Verdacht eines mechanischen Ileus diagnostisch wegweisend. Bei Verdacht auf eine CIPO muss mithilfe radiologischer und endoskopischer Verfahren sorgfältig nach einem mechanischen Hindernis gesucht werden. Aussagekräftige histologische Untersuchungen sind i. d. R. nur an transmuralen Darmwandbiopsien möglich. Mittels Dünndarmmanometrie kann die Diagnose einer CIPO auch im Intervall gesichert und zwischen Neuropathie und Myopathie unterschieden werden. Primäre Therapieziele sind: 1. Die Aufrechterhaltung eines adäquaten Ernährungszustandes durch orale und/oder enterale Ernährung; bei schweren Verlaufsformen kommt eine heimparenterale Ernährung und insbesondere bei Kindern als Ultima Ratio die Dünndarmtransplantation infrage. 2. Die Wiederherstellung einer intestinalen Propulsion durch Prokinetika. 3. Die Behandlung von Komplikationen wie bakterielle Fehlbesiedlung und ausgeprägte Schmerzen durch Antibiotika bzw. gezielte chirurgische Eingriffe. Unnötige Operationen sollten unbedingt vermieden werden, da sie das klinische Bild durch Bridenbildung wesentlich komplizieren können.
Abstract
Chronic intestinal pseudoobstruction (CIPO) is a rare disease in which a severe intestinal motility disorder impairs transit of chyme so that patients suffer from symptoms of a mechanical ileus without mechanical obstruction. CIPO may be a primary or secondary disorder due to muscular, neurologic, metabolic or endocrine disorders, but may also occur postinfectiously, postoperatively, following abdominal radiation or be caused by drugs or noxae. In severe cases, the typical history of (repeated) symptoms of mechanical obstruction leading to unsuccessful laparotomies will give key clues for diagnosis. If CIPO is suspected, mechanical obstruction must be searched for carefully by radiologic and endoscopic examinations. Histologic diagnosis usually demands full thickness biopsies of the intestinal wall. Small intestinal manometry allows diagnosis of CIPO even during oligosymptomatic intervals as well as differentiation among neuropathic and myopathic forms of the disease. The main therapeutic goals consist in: 1. Maintenance of an adequate nutritional state by oral and/or enteral nutrition; in severe cases home-parenteral nutrition may be required and particularly in children intestinal transplantation may be the ultima ratio. 2. Reconstitution of intestinal propulsion by prokinetic drugs. 3. Therapy of complications such as bacterial overgrowth and severe pain by antibiotics and specific surgical procedures. Unnecessary laparotomies should be strictly avoided because they may lead to adhesions and markedly complicate the clinical course.
Schlüsselwörter fehlen
Schlüsselwörter fehlen
Key words fehlen
Key words fehlen
5. Literaturverzeichnis
1
Faure C, Goulet O, Ategbo S. et al .
Chronic intestinal pseudoobstruction syndrome: Clinical analysis, outcome, and prognosis in 105 children. French-Speaking Group of Pediatric Gastroenterology.
Dig Dis Sci.
1999;
44
953-959
3
Auricchio A, Brancolini V, Casari G. et al .
The locus for a novel syndromic form of neuronal intestinal pseudoobstruction maps to Xq28.
Am J Hum Genet.
1996;
58
743-748
4
FitzPatrick D R, Strain L, Thomas A E. et al .
Neurogenic chronic idiopathic intestinal pseudo-obstruction, patent ductus arteriosus, and thrombocytopenia segregating as an X linked recessive disorder.
J Med Genet.
1997;
34
666-669
5
Malagelada J R, Distrutti E.
Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures.
Drugs.
1996;
52
494-506
8
Forchielli M L, Young M C, Flores A F, Richardson D, Lo C W.
Immune deficiencies in chronic intestinal pseudo-obstruction.
Acta Paediatr.
1997;
86
1077-1081
9
Husebye E.
The patterns of small bowel motility: Physiology and implications in organic disease and functional disorders.
Neurogastroenterol Motil.
1999;
11
141-161
10
DiMagno E P, Hendricks J C, Go V L, Dozois R R.
Relationships among canine fasting pancreatic and biliary secretions, pancreatic duct pressure, and duodenal phase III motor activity - Boldyreff (n??) revisited.
Dig Dis Sci.
1979;
24
689-693
11
Keller J, Groeger G, Cherian L, Günther B, Layer P.
Circadian coupling between pancreatic secretion and intestinal motility in humans.
Am J Physiol.
2001; in press;
12
Layer P, Chan A T, Go V L, DiMagno E P.
Human pancreatic secretion during phase II antral motility of the interdigestive cycle.
Am J Physiol.
1988;
254
G249-G253
13
von der nnn O, Layer P, Wollny C. et al .
Somatostatin 28 and coupling of human interdigestive intestinal motility and pancreatic secretion.
Gastroenterology.
1992;
103
974-981
14
Layer P, Chan A T, Go V L, Zinsmeister A R, DiMagno E P.
Cholinergic regulation of phase II interdigestive pancreatic secretion in humans.
Pancreas.
1993;
8
181-188
15
Layer P H, Chan A T, Go V L, Zinsmeister A R, DiMagno E P.
Adrenergic modulation of interdigestive pancreatic secretion in humans.
Gastroenterology.
1992;
103
990-993
16
Vantrappen G, Janssens J, Hellemans J, Ghoos Y.
The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.
J Clin Invest.
1977;
59
1158-1166
17
Husebye E, Skar V, Hoverstad T, Iversen T, Melby K.
Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy.
Gastroenterology.
1995;
109
1078-1089
23
Yamataka A, Ohshiro K, Kobayashi H. et al .
Abnormal distribution of intestinal pacemaker (C-KIT-positive) cells in an infant with chronic idiopathic intestinal pseudoobstruction.
J Pediatr Surg.
1998;
33
859-862
24
Wang Z Q, Watanabe Y, Toki A. et al .
Involvement of endogenous nitric oxide and c-kit-expressing cells in chronic intestinal pseudo-obstruction.
J Pediatr Surg.
2000;
35
539-544
26
Matulis S R, McJunkin B, Chang H H.
Familial visceral neuropathy as part of a diffuse neuronal syndrome: Four fatal cases in one sibship.
Am J Gastroenterol.
1994;
89
792-796
27
Fell J M, Smith V V, Milla P J.
Infantile chronic idiopathic intestinal pseudo-obstruction: The role of small intestinal manometry as a diagnostic tool and prognostic indicator.
Gut.
1996;
39
306-311
29
Koppelman R N, Stollman N H, Baigorri F, Rogers A I.
Acute small bowel pseudo-obstruction due to AL amyloidosis: A case report and literature review.
Am J Gastroenterol.
2000;
95
294-296
30
Sigurdsson L, Reyes J, Kocoshis S A. et al .
Intestinal transplantation in children with chronic intestinal pseudo-obstruction [see comments].
Gut.
1999;
45
570-574
31
Cucchiara S, Borrelli O, Salvia G. et al .
A normal gastrointestinal motility excludes chronic intestinal pseudoobstruction in children.
Dig Dis Sci.
2000;
45
258-264
34
Faber J, Fich A, Steinberg A. et al .
Familial intestinal pseudoobstruction dominated by a progressive neurologic disease at a young age.
Gastroenterology.
1987;
92
786-790
35
Chakravarti A, Blanton S, Kendall B J, McCallum R W.
Cosegregation of familial intestinal pseudoobstruction and presence of digital arches in a large multigenerational pedigree.
Dig Dis Sci.
1996;
41
1429-1433
36
Byrne W J, Cipel L, Ament M E, Gyepes M T.
Chronic idiopathic intestinal pseudo-obstruction syndrome. Radiologic signs in children with emphasis on differentiation from mechanical obstruction.
Diagn Imaging.
1981;
50
294-304
37
Luks F I, Chung M A, Brandt M L. et al .
Pneumatosis and pneumoperitoneum in chronic idiopathic intestinal pseudoobstruction.
J Pediatr Surg.
1991;
26
1384-1386
38
Barnett J L, McDonnell W M, Appelman H D, Dobbins W O.
Familial visceral neuropathy with neuronal intranuclear inclusions: Diagnosis by rectal biopsy.
Gastroenterology.
1992;
102
684-691
39
Borczuk A, Mannion C, Dickson D, Alt E.
Intestinal pseudo-obstruction and ischemia secondary to both beta 2-microglobulin and serum A amyloid deposition.
Mod Pathol.
1995;
8
577-582
40
Goulet O, Jobert-Giraud A, Michel J L. et al .
Chronic intestinal pseudo-obstruction syndrome in pediatric patients.
Eur J Pediatr Surg.
1999;
9
83-89
43
Bruyn G A, Bots G T, Van Wijhe M, Van Kersen F.
Chronic intestinal pseudoobstruction as a possible sequel to encephalitis.
Am J Gastroenterol.
1986;
81
50-54
44
McDonald G B, Schuffler M D, Kadin M E, Tytgat G N.
Intestinal pseudoobstruction caused by diffuse lymphoid infiltration of the small intestine.
Gastroenterology.
1985;
89
882-889
45
Arista-Nasr J, Gonzalez-Romo M, Keirns C, Larriva-Sahd J.
Diffuse lymphoplasmacytic infiltration of the small intestine with damage to nerve plexus. A cause of intestinal pseudo-obstruction.
Arch Pathol Lab Med.
1993;
117
812-819
46
Hutson J M, Chow C W, Borg J.
Intractable constipation with a decrease in substance P-immunoreactive fibres: Is it a variant of intestinal neuronal dysplasia?.
J Pediatr Surg.
1996;
31
580-583
47
Fogel S P, DeTar M W, Shimada H, Chandrasoma P T.
Sporadic visceral myopathy with inclusion bodies. A light-microscopic and ultrastructural study.
Am J Surg Pathol.
1993;
17
473-481
48
Arslan M, Bayraktar Y, Oksuzoglu G. et al .
Four cases with chronic intestinal pseudo-obstruction due to hollow visceral myopathy.
Hepatogastroenterology.
1999;
46
349-352
49
Ghoos Y F, Maes B D, Geypens B J. et al .
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test.
Gastroenterology.
1993;
104
1640-1647
50
Miller M A, Parkman H P, Urbain J L. et al .
Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: Lactulose accelerates small bowel transit.
Dig Dis Sci.
1997;
42
10-18
51
Cucchiara S, Annese V, Minella R. et al .
Antroduodenojejunal manometry in the diagnosis of chronic idiopathic intestinal pseudoobstruction in children.
J Pediatr Gastroenterol Nutr.
1994;
18
294-305
52
Di Lorenzo C, Reddy S N, Flores A F, Hyman P E.
Is electrogastrography a substitute for manometric studies in children with functional gastrointestinal disorders?.
Dig Dis Sci.
1997;
42
2310-2316
53
Faure C, Wolff V P, Navarro J.
Effect of meal and intravenous erythromycin on manometric and electrogastrographic measurements of gastric motor and electrical activity.
Dig Dis Sci.
2000;
45
525-528
55
Heneyke S, Smith V V, Spitz L, Milla P J.
Chronic intestinal pseudo-obstruction: Treatment and long-term follow-up of 44 patients.
Arch Dis Child.
1999;
81
21-27
56
Di Lorenzo C, Flores A F, Buie T, Hyman P E.
Intestinal motility and jejunal feeding in children with chronic intestinal pseudo-obstruction.
Gastroenterology.
1995;
108
1379-1385
57
Watanabe Y, Ito T, Ando H, Seo T, Nimura Y.
Manometric evaluation of gastrointestinal motility in children with chronic intestinal pseudo-obstruction syndrome.
J Pediatr Surg.
1996;
31
233-238
58
Hyman P E, Di Lorenzo C, McAdams L. et al .
Predicting the clinical response to cisapride in children with chronic intestinal pseudo-obstruction [see comments].
Am J Gastroenterol.
1993;
88
832-836
60
Mok M Y, Wong R W, Lau C S.
Intestinal pseudo-obstruction in systemic lupus erythematosus: An uncommon but important clinical manifestation.
Lupus.
2000;
9
11-18
62
Lennon V A, Sas D F, Busk M F. et al .
Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma [see comments].
Gastroenterology.
1991;
100
137-142
63
Gerl A, Storck M, Schalhorn A. et al .
Paraneoplastic chronic intestinal pseudoobstruction as a rare complication of bronchial carcinoid.
Gut.
1992;
33
1000-1003
64
Scolapio J S, Ukleja A, Bouras E P, Romano M.
Nutritional management of chronic intestinal pseudo-obstruction.
J Clin Gastroenterol.
1999;
28
306-312
68
Cavicchi M, Beau P, Crenn P, Degott C, Messing B.
Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure.
Ann Intern Med.
2000;
132
525-532
70
Moukarzel A A, Haddad I, Ament M E. et al .
230 patient years of experience with home long-term parenteral nutrition in childhood: Natural history and life of central venous catheters.
J Pediatr Surg.
1994;
29
1323-1327
71
Chasco Y A, Guibelalde d C, Moreno V J. et al .
Home parenteral nutrition in the management of patients with chronic idiopathic intestinal pseudo-obstruction.
Nutr Hosp.
1995;
10
264-267
72
Vargas J H, Sachs P, Ament M E.
Chronic intestinal pseudo-obstruction syndrome in pediatrics. Results of a national survey by members of the North American Society of Pediatric Gastroenterology and Nutrition.
J Pediatr Gastroenterol Nutr.
1988;
7
323-332
73
Di Lorenzo C, Reddy S N, Villanueva-Meyer J. et al .
Cisapride in children with chronic intestinal pseudoobstruction. An acute, double-blind, crossover, placebo-controlled trial.
Gastroenterology.
1991;
101
1564-1570
74
Camilleri M, Brown M L, Malagelada J R.
Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride.
Gastroenterology.
1986;
91
619-626
80
Vassallo M J, Camilleri M, Sullivan S N, Thomforde G M.
Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria [see comments].
J Clin Gastroenterol.
1992;
14
255-259
82
Peracchi M, Basilisco G, Bareggi B. et al .
Plasma somatostatin levels in patients with chronic idiopathic intestinal pseudo-obstruction.
Am J Gastroenterol.
1997;
92
1884-1886
83
Haruma K, Wiste J A, Camilleri M.
Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders.
Gut.
1994;
35
1064-1069
84
Verne G N, Eaker E Y, Hardy E, Sninsky C A.
Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction.
Dig Dis Sci.
1995;
40
1892-1901
85
Bouhnik Y, Alain S, Attar A. et al .
Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome.
Am J Gastroenterol.
1999;
94
1327-1331
87
Attar A, Flourie B, Rambaud J C. et al .
Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: A crossover, randomized trial.
Gastroenterology.
1999;
117
794-797
88
Vanderhoof J A, Young R J, Murray N, Kaufman S S.
Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome.
J Pediatr Gastroenterol Nutr.
1998;
27
155-160
90
Di Stefano M, Malservisi S, Veneto G, Ferrieri A, Corazza G R.
Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.
Aliment Pharmacol Ther.
2000;
14
551-556
92
Ginies J L, Francois H, Joseph M G. et al .
A curable cause of chronic idiopathic intestinal pseudo-obstruction in children: Idiopathic myositis of the small intestine.
J Pediatr Gastroenterol Nutr.
1996;
23
426-429
93
Yokota T, Suda T, Tsukioka S. et al .
The striking effect of hyperbaric oxygenation therapy in the management of chronic idiopathic intestinal pseudo-obstruction.
Am J Gastroenterol.
2000;
95
285-288
94
Schuffler M D, Leon S H, Krishnamurthy S.
Intestinal pseudoobstruction caused by a new form of visceral neuropathy: Palliation by radical small bowel resection.
Gastroenterology.
1985;
89
1152-1156
95
Mughal M M, Irving M H.
Treatment of end stage chronic intestinal pseudo-obstruction by subtotal enterectomy and home parenteral nutrition.
Gut.
1988;
29
1613-1617
96
Murr M M, Sarr M G, Camilleri M.
The surgeon’s role in the treatment of chronic intestinal pseudoobstruction.
Am J Gastroenterol.
1995;
90
2147-2151
97
Hase T, Kodama M, Kishida A. et al .
The application of radio-opaque markers prior to ileostomy in an infant with chronic intestinal pseudo-obstruction: Report of a case.
Surg Today.
1998;
28
83-86
99
Goulet O, Jan D, Lacaille F. et al .
Intestinal transplantation in children: Preliminary experience in Paris.
JPEN J Parenter Enteral Nutr.
1999;
23
S121-S125
